The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
Abstract
The striatum is viewed as a structure performing fast neurotransmitter-mediated operations through somatotopically organized projections to medium-size spiny neurons. This view is contrasted with another view that depicts the striatum as a site of diffuse modulatory influences mediated by cholinergic interneurons and by dopamine and N-methyl-D-aspartate receptors. These two operational and organizational modes both contribute, through their mutual interaction, to the function of basal ganglia. Detailed knowledge of the neural mechanisms by which such interactions take place and are expressed into behaviour, can provide new insight into the physiopathology and new clues for therapy of disorders of basal ganglia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The striatum is thought to be a region of broad modulatory effects mediated by cholinergic interneurons, dopa mine, and N-methyl-D-aspartate (NMDA) receptors (Chiara et al., 1994).”
From Predictive coding in neuropsychiatric disorders: a systematic transdiagnostic review. (2025) · cites this paper as Chiara et al., 1994
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Seeman, P. M. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,888
Neurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576
The neostriatal mosaic: multiple levels of compartmental organization
Gerfen, C. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90355-c · Cited by 1,471
Hulme, E. C., Birdsall, N. J. M., & Buckley, N. J. (1990) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003221 · Cited by 1,366
The mysterious motor function of the basal ganglia
MARSDEN, C. D. (1982) · Neurology · doi:10.1212/wnl.32.5.514 · Cited by 924
SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio, L. C., Barnett, A., Leitz, F. H., Houser, V. P., & Korduba, C. A. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21599-3 · Cited by 896
Research works printed but not linked: 17
- Kitai, 1993, Adv. Neurol., 60, 40
- Herrling, 1992, Arzneimit. Forsch. Drug Res., 42, 202
- Morelli, 1992, J. Pharmacol. Exp. Ther., 260, 402
- Meredithy, 1990, Neurology, 296, 204
- Kimura, 1984, 81, 4998
- Maura, 1988, J. Pharmacol. Exp. Ther., 247, 680
- Jarvie, 1993, Adv. Neurol., 60, 325
- Iorio, 1983, J. Pharmacol. Exp. Ther., 226, 462
- Damsma, 1991, J. Pharmacol. Exp. Ther., 259, 1064
- Imperato, 1993, J. Pharmacol. Exp. Ther., 366, 557
- Meller, 1987, Mol. Pharmacol., 31, 592
- Seeman, 1981, Pharmacol. Rev., 32, 229
- Le Moine, 1990, 87, 230
- Le Moine, 1991, 88, 4205
- Di Chiara G.; Morelli M. Basal Ganglia IV, Proc. IVth Meeting Int. Basal Ganglia Society Percheron G.; McKenzie J.S. Plenum Press (in press.)
- Di Chiara, 1993, Adv. Neurol., 60, 102
- Riederer, 1993, Adv. Neurol., 60, 626
Cited by
Sorted by citations
Items 101–200 of 467
Cholinergic modulation of nucleus accumbens medium spiny neurons
de Rover, M., Lodder, J. C., Kits, K. S., Schoffelmeer, A. N. M., & Brussaard, A. B. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02289.x · Cited by 96
Pisani, A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00137-0 · Cited by 94
Andersen, M. B., Fink‐Jensen, A., Peacock, L., Gerlach, J., Bymaster, F. P., Lundbæk, J. A., & Werge, T. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300151 · Cited by 93
The basal ganglia: anatomy, physiology, and pharmacology
Tisch, S. H., Silberstein, P., Limousin, P. D., & Jahanshahi, M. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.06.004 · Cited by 96
Haber, S. N., Adler, A., & Bergman, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10020-3 · Cited by 94
Chiara, G. D. (1997) · PubMed Central · Cited by 89
Miki, K., Ishibashi, S., Sun, L., Xu, H., Ohashi, W., Kuroiwa, T., & Mizusawa, H. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21925 · Cited by 89
Social play alters regional brain opioid receptor binding in juvenile rats
Vanderschuren, L. J. M. J., Stein, E. A., Wiegant, V. M., & Van Ree, J. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00256-p · Cited by 88
Functional organization of forebrain pathways for song production and perception
Margoliash, D. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19971105)33:5 · Cited by 206
Food Addiction and Binge Eating: Lessons Learned from Animal Models
Novelle, M. G., & Diéguez, C. (2018) · Nutrients · doi:10.3390/nu10010071 · Cited by 90
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
Ztaou, S., & Amalric, M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.019 · Cited by 88
Berardis, D. D., Marini, S., Fornaro, M., Srinivasan, V., Iasevoli, F., Tomasetti, C., Valchera, A., Perna, G., Quera-Salva, M.-A., Martinotti, G., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612458 · Cited by 86
Sano, H., Yasoshima, Y., Matsushita, N., Kaneko, T., Kohno, K., Pastan, I. H., & Kobayashi, K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09078.2003 · Cited by 84
Coordination of rapid cholinergic and dopaminergic signaling in striatum during spontaneous movement
Howe, M. W., Ridouh, I., Mascaro, A. L. A., Larios, A., Azcorra, M., & Dombeck, D. A. (2019) · eLife · doi:10.7554/elife.44903 · Cited by 84
Regulation of AMPA Receptors by Phosphorylation
Carvalho, A. L., Duarte, C. B., & Carvalho, A. P. (2000) · Neurochemical Research · doi:10.1023/a:1007644128886 · Cited by 87
Excitatory actions of serotonin on GABAergic neurons of the medial septum and diagonal band of broca
Alreja, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199601)22:1 · Cited by 67
Blanchet, P. J., Papa, S. M., Metman, L. V., Mouradian, M. M., & Chase, T. N. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00038-3 · Cited by 84
Immunolocalization of CB 1 receptor in rat striatal neurons: A confocal microscopy study
Fusco, F. R., Martorana, A., Giampà, C., March, Z. D., Farini, D., D’Angelo, V., Sancesario, G., & Bernardi, G. (2004) · Synapse · doi:10.1002/syn.20047 · Cited by 83
Cozzi, A., Attucci, S., Peruginelli, F., Marinozzi, M., Luneia, R., Pellicciari, R., & Moroni, F. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01489.x · Cited by 78
Cousins, M. S., Carriero, D. L., & Salamone, J. D. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00008-3 · Cited by 77
Abercrombie, E. D., & DeBoer, P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08498.1997 · Cited by 76
von der Kammer, H., Mayhaus, M., Albrecht, C., Enderich, J., Wegner, M., & Nitsch, R. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14538 · Cited by 76
El‐Amamy, H., & Holland, P. C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05402.x · Cited by 75
Rahman, S., & McBride, W. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00739.x · Cited by 75
Holt, D. J., Bachus, S. E., Hyde, T. M., Wittie, M., Herman, M. M., Vangel, M. G., Saper, C. B., & Kleinman, J. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.007 · Cited by 74
Cholinergic Functioning in Stimulant Addiction
Sofuoglu, M., & Mooney, M. E. (2009) · CNS Drugs · doi:10.2165/11310920-000000000-00000 · Cited by 77
Yamada, M., Basile, A. S., Fedorova, I. D., Zhang, W., Duttaroy, A., Cui, Y., Lamping, K. G., Faraci, F. M., Deng, C., & Wess, J. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.022 · Cited by 77
Popoli, P., Giménez‐Llort, L., Pèzzola, A., Reggio, R., Martı́nez, E., Fuxé, K., & Ferré, S. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13143-8 · Cited by 74
Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies
Tonon, A. C., Pilz, L. K., Markus, R. P., Hidalgo, M. P. L., & Elisabetsky, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638981 · Cited by 79
Muscarinic Acetylcholine Receptor Knockout Mice
Wess, J., Zhang, W., Duttaroy, A., Miyakawa, T., Gomeza, J., Cui, Y., Basile, A. S., Bymaster, F. P., McKinzie, D. L., Felder, C. C., et al. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_3 · Cited by 73
Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice
Schmidt, L. S., Thomsen, M., Weikop, P., Dencker, D., Wess, J., Woldbye, D. P. D., Wörtwein, G., & Fink‐Jensen, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2225-4 · Cited by 74
Wang, J. Q., & McGinty, J. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00597-8 · Cited by 73
Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson's disease
Salin, P., López, I. P., Kachidian, P., Barroso‐Chinea, P., Rico, A. J., Gómez-Bautista, V., Coulon, P., Goff, L. K., & Lanciego, J. L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.006 · Cited by 72
Wang, J. Q., & McGinty, J. F. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36678-9 · Cited by 72
Quik, M., Police, S. M. C., He, L., Monte, D. A. D., & Langston, J. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00130-5 · Cited by 72
Martins-Silva, C., Jaeger, X. D., Guzmán, M. S., Lima, R. D. F., Santos, M., Kushmerick, C., Gomez, M. V., Caron, M. G., Prado, M. A. M., & Prado, V. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017611 · Cited by 71
Reaction Time Responding in Rats
Blokland, A. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00013-x · Cited by 70
Lee, K., Dixon, A. K., Freeman, T. C., & Richardson, P. J. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.441bk.x · Cited by 70
Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons
Wirkner, K., Aßmann, H., Köles, L., Gerevich, Z., Franke, H., Nörenberg, W., Boehm, R., & Illés, P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703234 · Cited by 69
Starr, M. S. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251229 · Cited by 69
Jia, Z., & Misra, H. P. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.04.003 · Cited by 68
Thiel, C. M., & Schwarting, R. K. W. (2001) · Neuropsychobiology · doi:10.1159/000054889 · Cited by 68
Pharmacological animal models of Tourette syndrome
Bronfeld, M., Israelashvili, M., & Bar‐Gad, I. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.010 · Cited by 70
The cholinergic system and neostriatal memory functions
Havekes, R., Abel, T. G., & van der Zee, E. A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.047 · Cited by 69
Agnoli, L., Mainolfi, P., Invernizzi, R. W., & Carli, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.236 · Cited by 70
Dopaminergic Regulation of Striatal Interneurons in Reward and Addiction: Focus on Alcohol
Clarke, R. B. C., & Adermark, L. (2015) · Neural Plasticity · doi:10.1155/2015/814567 · Cited by 68
Role of Cdk5 in Drug Abuse and Plasticity
Benavides, D. R., & Bibb, J. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.041 · Cited by 64
Cadoni, C., Pinna, A., Russi, G., Consolo, S., & Chiara, G. D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00507-2 · Cited by 64
Self-citationDencker, D., Thomsen, M., Wörtwein, G., Weikop, P., Cui, Y., Jeon, J., Wess, J., & Fink‐Jensen, A. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200110q · Cited by 63
Sakae, N., Yamasaki, N., Kitaichi, K., Fukuda, T., Yamada, M., Yoshikawa, H., Hiranita, T., Tatsumi, Y., Kira, J., Yamamoto, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn215 · Cited by 64
Morari, M., O'Connor, W. T., Ungerstedt, U., Bianchi, C. L., & Fuxé, K. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00556-0 · Cited by 63
Acetylcholine/dopamine interaction in planaria
Buttarelli, F. R., Pontieri, F. E., Margotta, V., & Palladini, G. (2000) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(99)00111-5 · Cited by 62
Koshimizu, H., Leiter, L. M., & Miyakawa, T. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-10 · Cited by 61
Marti, M., Mela, F., Bianchi, C., Beani, L., & Morari, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01169.x · Cited by 62
Gobert, A., Cara, B. D., Cistarelli, L., & Millan, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046383 · Cited by 60
Consolo, S., Baronio, P., Guidi, G., & Chiara, G. D. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00421-1 · Cited by 59
Self-citationThe involvement of dopamine in the striatum in passive avoidance training in the chick
Stewart, M. G., Kabai, P., Harrison, E., Steele, R. J., Kossut, M. M., Gierdalski, M., & Csillag, A. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00345-j · Cited by 59
Vinson, P. N., & Justice, J. B. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(96)02213-3 · Cited by 58
Nóbrega, J. N., Richter, A., Tozman, N., Jiwa, D., & Löscher, W. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00511-0 · Cited by 58
Daunais, J. B., & McGinty, J. F. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00226-i · Cited by 59
Veeraragavan, S., Graham, D. F., Bui, N., Yuva‐Paylor, L. A., Wess, J., & Paylor, R. E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.018 · Cited by 63
Meshul, C. K., Kamel, D., Moore, C., Kay, T. S., & Krentz, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7900 · Cited by 57
Mieda, M., Haga, T., & Saffen, D. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5177 · Cited by 57
Dencker, D., Weikop, P., Sørensen, G., Woldbye, D. P. D., Wörtwein, G., Wess, J., & Fink‐Jensen, A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2751-8 · Cited by 56
Correlating Physiology with Gene Expression in Striatal Cholinergic Neurones
Richardson, P. J., Dixon, A. K., Lee, K. C., Bell, M. I., Cox, P. J., Williams, R. E., Pinnock, R. D., & Freeman, T. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740839.x · Cited by 56
Antipsychotic-Induced Rabbit Syndrome
Schwartz, M., & Hocherman, S. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00002 · Cited by 55
Sakakibara, R., Nakazawa, K., Uchiyama, T., Yoshiyama, M., Yamanishi, T., & Hattori, T. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(02)00180-7 · Cited by 55
Schoffelmeer, A. N. M., Vanderschuren, L. J. M. J., Vries, T. J. D., Hogenboom, F., Wardeh, G., & Mulder, A. H. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03496.2000 · Cited by 55
Loss of nigral excitation of cholinergic interneurons contributes to parkinsonian motor impairments
Cai, Y., Nielsen, B. E., Boxer, E. E., Aoto, J. N., & Ford, C. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.028 · Cited by 55
Bell, M. I., Richardson, P. J., & Lee, K. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00815.x · Cited by 54
Potential role of muscarinic receptors in schizophrenia
Bymaster, F. P., Shannon, H. E., Rasmussen, K., DeLapp, N. W., Ward, J. S., Calligaro, D. O., Mitch, C. H., Whitesitt, C. A., Ludvigsen, T. S., Sheardown, M. J., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(98)00597-9 · Cited by 54
Hernández, L. F., Segovia, G., & Mora, F. (2003) · Neurochemical Research · doi:10.1023/a:1026115607216 · Cited by 54
Martire, M., D’Amico, M., Panza, E., Miceli, F., Viggiano, D., Lavergata, F., Iannotti, F. A., Barrese, V., Preziosi, P., Annunziato, L., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04562.x · Cited by 53
Regulation of Neurotransmitter Interactions in the Ventral Striatum
McGinty, J. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09265.x · Cited by 53
Liste, I., Rozas, G., Guerra, M. J., & Labandeira-García, J. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00958-s · Cited by 53
Perry, K. W., Nisenbaum, L. K., George, C. A., Shannon, H. E., Felder, C. C., & Bymaster, F. P. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01017-9 · Cited by 52
Wang, J. Q., & McGinty, J. F. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01244-9 · Cited by 51
Chen, H., McCarty, D. M., Bruce, A. T., Suzuki, K., & Suzuki, K. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990215)55:4 · Cited by 71
Fink‐Jensen, A., Schmidt, L. S., Dencker, D., Schülein, C., Wess, J., Wörtwein, G., & Woldbye, D. P. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.018 · Cited by 50
Tomiyama, M., Palacios, J. M., Cortés, R., Vilaró, M. T., & Mengod, G. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00022-3 · Cited by 50
Thomsen, M., Conn, P. J., Lindsley, C. W., Wess, J., Boon, J. Y., Fulton, B. S., Fink‐Jensen, A., & Caine, S. B. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162057 · Cited by 49
Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD
Hendler, T. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(03)00091-x · Cited by 49
Prüß, H., Wenzel, M. E., Eulitz, D., Thomzig, A., Karschin, A., & Veh, R. W. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00649-6 · Cited by 49
Delfs, J. M., Anegawa, N. J., & Chesselet, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00572-m · Cited by 49
Protection against dopaminergic nigrostriatal cell death by excitatory input ablation
Takada, M., Matsumura, M., Kojima, J., Yamaji, Y., Inase, M., Tokuno, H., Nambu, A., & Imai, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00062.x · Cited by 49
Herrero, M. T., Augood, S. J., Asensi, H., Hirsch, É. C., Agid, Y., Obeso, J. A., & Emson, P. C. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00157-x · Cited by 48
Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice
Thomsen, M., Wess, J., Fulton, B. S., Fink‐Jensen, A., & Caine, S. B. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1740-z · Cited by 48
Anatomy, physiology, and pharmacology of the basal ganglia
Pollack, A. E. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70032-3 · Cited by 48
Kim, D. S., & Palmiter, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252753799 · Cited by 47
Jenner, P. G. (2000) · Journal of Neurology · doi:10.1007/pl00007760 · Cited by 47
Turgeon, S. M., Pollack, A. E., Schusheim, L., & Fink, J. S. (1996) · Brain Research · doi:10.1016/0006-8993(95)01223-0 · Cited by 47
Tascedda, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00034-2 · Cited by 47
Millan, M. J., Cara, B. D., Hill, M. P., Jackson, M., Joyce, J. N., Brotchie, J. M., McGuire, S., Crossman, A. R., Smith, L. A., Jenner, P. G., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062414 · Cited by 47
Nestby, P., Vanderschuren, L. J. M. J., Vries, T. J. D., Mulder, A. H., Wardeh, G., Hogenboom, F., & Schoffelmeer, A. N. M. (1999) · Psychopharmacology · doi:10.1007/s002130050838 · Cited by 46
Social isolation and social interaction alter regional brain opioid receptor binding in rats
Vanderschuren, L. J. M. J., Stein, E. A., Wiegant, V. M., & van Ree, J. M. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00010-m · Cited by 48
Hanania, T., Hillman, G. R., & Johnson, K. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990301)31:3 · Cited by 46
Neurobiological issues in Tourette syndrome
Singer, H. S. (1994) · Brain and Development · doi:10.1016/0387-7604(94)90122-8 · Cited by 46
Consolo, S., Caltavuturo, C., Colli, E., Recchia, M., & Chiara, G. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00309-1 · Cited by 44
Self-citationRehders, J. H., Löscher, W., & Richter, A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00073-7 · Cited by 44
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways
Fantin, M., Marti, M., Auberson, Y. P., & Morari, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04966.x · Cited by 42
Metadata
- Authors
- Di Chiara, G., Morelli, M., & Consolo, S.
- Affiliations
- University of Cagliari (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- ORCID
- Morelli, Micaela
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 1994-06
- Volume
- 17
- Issue
- 6
- Pages
- 228-233
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W1990162104
- Semantic Scholar
- 6620d60a424c6c77bf86292e9bd8b24706c6c57f
- Cited by
- 467
- References
- 72
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 11 · 2016: 9 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 13
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- striatum, acetylcholine, dopamine, NMDA receptor, cholinergic interneurons, medium spiny neurons, basal ganglia, neurotransmitter interactions, basal ganglia disorders, neuromodulation
- MeSH terms
- Acetylcholine, Animals, Corpus Striatum, Dopamine, Humans, Synaptic Transmission, Receptors, Dopamine, N-Methylaspartate, Neurotransmitter Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review